Discontinuation report IMMUCYST
| Report ID | 33704 |
| Drug Identification Number | 02194376 |
| Brand name | IMMUCYST |
| Common or Proper name | Bacillus Calmette-Guérin (BCG), substrain Connaught |
| Company Name | SANOFI PASTEUR LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BACILLUS CALMETTE-GUERIN |
| Strength(s) | 81MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | INTRAVESICAL |
| Packaging size | 1 x 81 mg vial (1 Treatment) |
| ATC code | L03AX |
| ATC description | IMMUNOSTIMULANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-01-01 |
| Actual discontinuation date | 2018-01-01 |
| Remaining supply date | 2017-12-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | The remaining supply of IMMUCYST® in the Canadian market will expire on December 31, 2017. |
| Company comments | The production of IMMUCYST® has been discontinued and supply to the Canadian market will be discontinued as of January 01, 2018. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-01-02 | English | Compare |
| v2 | 2017-12-19 | French | Compare |
| v1 | 2017-12-19 | English | Compare |
Showing 1 to 3 of 3